Background: Neuroendocrine neoplasias (NENs) are a rare group of tumors with different prognosis and response to therapy. Their heterogeneity is dependent on the site of origin, morpholo
Data shows clinical and biochemical features in patients with peritoneal carcinomatosis from different primary tumors. A list of abbreviations is included in the second file.
This was a national, multi-center, open-label, phase IIIb trial to determine the efficacy and safety of treatment with ribociclib (LEE011) plus letrozole in patients with HR+, HER2-negative advanced (
for pWML cases and non-pWML cases. Mean values above are adjusted for age.ap-values listed are derived from the univariate contrasts controlling for PCA.